← Back to Search

Web-Based Exercise Program for Obesity

N/A

Waitlist Available

Led By Jacob Kariuki, PhD, NP

Research Sponsored by Emory University

Eligibility Criteria Checklist

Specific guidelines that determine who can or cannot participate in a clinical trial

Must have

Be older than 18 years old

Timeline

Screening 3 weeks

Treatment Varies

Follow Up baseline, month 6

Awards & highlights

No Placebo-Only Group

Summary

This trial tests if exercise can help obese adults stay fit and healthy.

Who is the study for?

This trial is for adults with obesity who are not very active, have a BMI of 30 or higher, and don't exercise much (less than 150 minutes of moderate activity per week). They must be able to use the internet regularly and track their physical activity. People can't join if they're pregnant, planning to get pregnant soon, have mobility issues, need supervised exercise due to certain conditions like stroke or heart disease unless cleared by a doctor.

What is being tested?

The study tests the PATH intervention—a web-based program designed to increase physical activity—against an attention control group that receives dietary education. Participants will also use a physical activity tracker to monitor their progress.

What are the potential side effects?

Since this trial involves lifestyle changes rather than medication, side effects may include muscle soreness or injury from new physical activities. The risk is low but participants should start any new exercise gradually and under guidance.

Timeline

Screening ~ 3 weeks3 visits

Treatment ~ Varies

Follow Up ~ baseline, month 6

Screening ~ 3 weeks

Treatment ~ Varies

Follow Up ~baseline, month 6

This trial's timeline: 3 weeks for screening, Varies for treatment, and baseline, month 6 for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.

Primary study objectives

Change in 2013 Atherosclerotic Cardiovascular Disease (ASCVD) Risk Calculator

Change in Number of Participants Adhering to PA Guidelines

Change in Step Count

+1 more

Secondary study objectives

Change in Adiponectin

Change in Diastolic Blood Pressure

Change in Hemoglobin A1c

+7 more

Awards & Highlights

No Placebo-Only Group

All patients enrolled in this study will receive some form of active treatment.

Trial Design

2Treatment groups

Experimental Treatment

Active Control

Group I: PATH InterventionExperimental Treatment3 Interventions

Insufficiently active adults with obesity assigned to the PATH intervention.

Group II: Attention Control GroupActive Control3 Interventions

Insufficiently active adults with obesity assigned to the attention control group. At the end of the 6-month study period, participants will receive access to the PATH program, with out the coaching component.

Treatment

First Studied

Drug Approval Stage

How many patients have taken this drug

PATH Intervention

2021

N/A

~80

Dietary education

2015

N/A

~70